Structure-Function Agreement Is Better Than Commonly Thought in Eyes With Early Glaucoma.
Hood Donald C, Tsamis Emmanouil, Bommakanti Nikhil K, Joiner Devon B, Al-Aswad Lama A, Blumberg Dana M, Cioffi George A, Liebmann Jeffrey M, De Moraes Carlos G
AI Summary
This study found excellent structure-function agreement in early glaucoma using automated OCT and both 24-2/10-2 visual fields, suggesting damage correlation is better than commonly perceived for diagnosis and monitoring.
Abstract
Purpose
To assess the agreement between structural (optical coherence tomography [OCT]) and functional (visual field [VF]) glaucomatous damage with an automated method and deviation/probability maps, and to compare this method to a metric method.
Methods
Wide-field spectral-domain OCT scans, including the disc and macula, and 24-2 and 10-2 VFs were obtained from 45 healthy control (H) eyes/individuals, and 53 eyes/patients with 24-2 mean deviation (MD) better than -6 dB diagnosed as "definite glaucoma" (DG) by experts. Abnormal structure-abnormal function (aS-aF) agreement was assessed with an automated topographic (T) method based upon VF pattern deviation and OCT probability maps. Results were compared to a metric (M) method optimized for accuracy, (abnormal 24-2 glaucoma hemifield test [GHT] or pattern standard deviation [PSD], or 10-2 PSD AND abnormal OCT [quadrant]).
Results
For the T-method, 47 (88.7%) of the 53 DG eyes showed aS-aF agreement, compared to 2 (4.5%) of the 45 H eyes. The aS-aF agreement for these two H eyes was easily identified as mistaken, and did not replicate on a subsequent test. Without the 10-2, the aS-aF agreement decreased from 47 to 34 (64.2%) of 53 DG eyes. For the M-method, 37 (69.8%) of the 53 DG eyes showed aS-aF agreement, while omitting the 10-2 VF resulted in agreement in only 33 (62.3%) eyes.
Conclusions
There is good agreement between structural and functional damage, even in eyes with confirmed early glaucomatous damage, if both 24-2 and 10-2 VFs are obtained, and abnormal locations on the VFs are compared to abnormal regions seen on OCT macular and disc scans. This can be done in an objective, automated fashion. (ClinicalTrials.gov number, NCT02547740.).
MeSH Terms
Shields Classification
Key Concepts6
An automated topographic (T) method, based upon visual field (VF) pattern deviation and OCT probability maps, showed abnormal structure-abnormal function (aS-aF) agreement in 47 (88.7%) of 53 eyes with definite glaucoma (DG) and 24-2 mean deviation (MD) better than -6 dB.
Omitting the 10-2 visual field (VF) decreased the abnormal structure-abnormal function (aS-aF) agreement from 47 to 34 (64.2%) of 53 definite glaucoma (DG) eyes when using the automated topographic (T) method.
Good agreement between structural (optical coherence tomography [OCT]) and functional (visual field [VF]) damage can be achieved in eyes with confirmed early glaucomatous damage if both 24-2 and 10-2 VFs are obtained, and abnormal locations on the VFs are compared to abnormal regions seen on OCT macular and disc scans, using an objective, automated fashion.
For the automated topographic (T) method, 2 (4.5%) of 45 healthy control (H) eyes showed abnormal structure-abnormal function (aS-aF) agreement, which was easily identified as mistaken and did not replicate on a subsequent test.
A metric (M) method, optimized for accuracy (abnormal 24-2 glaucoma hemifield test [GHT] or pattern standard deviation [PSD], or 10-2 PSD AND abnormal OCT [quadrant]), showed abnormal structure-abnormal function (aS-aF) agreement in 37 (69.8%) of 53 definite glaucoma (DG) eyes.
Omitting the 10-2 visual field (VF) resulted in abnormal structure-abnormal function (aS-aF) agreement in only 33 (62.3%) of 53 definite glaucoma (DG) eyes when using the metric (M) method.
Related Articles5
Comparative Analysis of 24-2C, 24-2, and 10-2 Visual Field Tests for Detecting Mild-Stage Glaucoma With Central Visual field Defects.
Observational StudyMicroperimetry Characteristics of Regions With a Truly Nonresponding Location: Implications for Atrophic Age-Related Macular Degeneration.
Observational StudyValidation of a Wearable Virtual Reality Perimeter for Glaucoma Staging, The NOVA Trial: Novel Virtual Reality Field Assessment.
Clinical TrialEvaluation of the long-term variability of macular OCT/OCTA and visual field parameters.
Observational StudyOptic Disc Microvasculature Reduction and Visual Field Progression in Primary Open-Angle Glaucoma.
Case SeriesIs this article assigned to the wrong chapter(s)? Let us know.